Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE‐1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies

Documenti analoghi

• Synthesis, AChE and BuChE Inhibitory Activity, and Computational Evaluation of Pyrazole‐Based Acrylonitrile Derivatives
  di: Abdullah Biçer
  Pubblicazione: (2025)
• Licochalcone A as Novel Multitarget Inhibitors via AChE, BuChE, and Synapsin III for Therapeutic Intervention Against Alzheimer’s Disease: Computer‐Aided Drug Design
  di: Ali Alimari, et al.
  Pubblicazione: (2026)
• Efficient, rapid, and high‐yield synthesis of aryl Schiff base derivatives and their in vitro and in silico inhibition studies of hCA I, hCA II, AChE, and BuChE
  di: Musa Özil, et al.
  Pubblicazione: (2024)
• Sleep Deprivation Aggravates Periodontitis Through Trigeminal‐Periodontal Neuroimmune Pathway Mediated by the AChE‐ACh‐α7nAChR Axis
  di: Kehao Liu, et al.
  Pubblicazione: (2025)
• Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold from the soft coral Sclerophytum humesi.
  di: Luu, Phuong Vu, et al.
  Pubblicazione: (2026)